Lantern Pharma Closes $4M Direct Offering, Adds Up To $4M Warrant Upside

Lantern Pharma successfully closed a registered direct offering, raising approximately $4 million by issuing shares at $1.09 each. The company also issued private warrants that could provide an additional $4 million, exercisable at the same price, contingent upon stockholder approval and expiring five years post-approval.